Abstract

Heart transplantation remains the gold standard treatment for patients with end-stage heart failure. In the USA, the number of available donors has remained stable despite the steadily increasing need for organs. Optimal donor selection and management are critical to deriving the greatest benefit from this limited resource. Methods to expand the donor pool without compromising long-term outcomes for heart recipients are needed.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call